The percentage of KRAS positive cases by histology based on liquid samples was 22.6% (7 of 31) in patients with mucinous adenocarcinoma and 58.1% (18 of 31) in patients with nonmucinous adenocarcinoma. This evidence concerns the gene KRAS and adenocarcinoma.